CD8A and neoplasm: Another study indicated that after PLX3397 treatment in mice with breast cancer, there was a significant depletion of macrophages in tumor tissues accompanied by an increase in the ratio of CD8+/CD4+ T cells and significantly reduced tumor growth (112).